Jiachu Li

706 total citations
12 papers, 546 citations indexed

About

Jiachu Li is a scholar working on Molecular Biology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Jiachu Li has authored 12 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hepatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Jiachu Li's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver physiology and pathology (4 papers) and Cancer Mechanisms and Therapy (3 papers). Jiachu Li is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver physiology and pathology (4 papers) and Cancer Mechanisms and Therapy (3 papers). Jiachu Li collaborates with scholars based in China, United States and Germany. Jiachu Li's co-authors include Jia Fan, Kang–Da Liu, Ai‐Wu Ke, Yang Xu, Vijay H. Shah, Ningling Kang, Jincai Wu, Xiaoyu Xiang, Chunsheng Liu and Zhengji Song and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Jiachu Li

11 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiachu Li China	9	345	123	123	120	100	12	546
Jincai Wu China	12	309 0.9×	106 0.9×	185 1.5×	138 1.1×	50 0.5×	29	566
Warren Shih Canada	9	351 1.0×	54 0.4×	132 1.1×	269 2.2×	55 0.6×	9	617
M W Büchler Switzerland	6	209 0.6×	88 0.7×	94 0.8×	216 1.8×	32 0.3×	9	456
María Giselle Peters Argentina	10	300 0.9×	41 0.3×	89 0.7×	177 1.5×	120 1.2×	17	469
Eric T. Sawey United States	5	331 1.0×	116 0.9×	135 1.1×	166 1.4×	18 0.2×	6	528
Julien Deheuninck France	7	343 1.0×	109 0.9×	44 0.4×	110 0.9×	49 0.5×	8	455
Di‐Peng Ou China	11	279 0.8×	268 2.2×	182 1.5×	137 1.1×	63 0.6×	14	628
Kouichiro Goto Japan	11	789 2.3×	54 0.4×	108 0.9×	307 2.6×	59 0.6×	13	930
Sander P.J. Joosten Netherlands	10	288 0.8×	36 0.3×	101 0.8×	236 2.0×	95 0.9×	12	481
Candice Alexandra Grzelak United States	8	193 0.6×	80 0.7×	133 1.1×	199 1.7×	53 0.5×	10	420

Countries citing papers authored by Jiachu Li

Since Specialization

Citations

This map shows the geographic impact of Jiachu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiachu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiachu Li more than expected).

Fields of papers citing papers by Jiachu Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiachu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiachu Li. The network helps show where Jiachu Li may publish in the future.

Co-authorship network of co-authors of Jiachu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiachu Li. A scholar is included among the top collaborators of Jiachu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiachu Li. Jiachu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Li, Jiachu, et al.. (2025). Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Donafenib and Camrelizumab in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Retrospective, Single-Arm Study. Journal of Hepatocellular Carcinoma. Volume 12. 1353–1367.

He, Qiang, et al.. (2024). Hepatic artery infusion chemotherapy (HAIC) combined with tislelizumab and lenvatinib for initial unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus: A prospective, single-arm phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4103–4103. 3 indexed citations

He, Qiang, et al.. (2023). Hepatic artery infusion chemotherapy combined with donafenib and camrelizumab in patients with unresectable hepatocellular carcinoma presenting portal vein tumor thrombus: A prospective, single-arm study.. Journal of Clinical Oncology. 41(16_suppl). e16134–e16134. 1 indexed citations

Zhang, Xingping, et al.. (2018). Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma. Scientific Reports. 8(1). 17415–17415. 26 indexed citations

Zhou, Kun, et al.. (2018). <em>MSX1</em> induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer. OncoTargets and Therapy. Volume 11. 4769–4780. 24 indexed citations

Yan, Qingqing, Wenjing Zhang, Wu Yao, et al.. (2015). KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. Oncotarget. 6(28). 25402–25417. 45 indexed citations

Bi, Yan, Jiachu Li, Baoan Ji, et al.. (2014). Sphingosine-1-Phosphate Mediates a Reciprocal Signaling Pathway between Stellate Cells and Cancer Cells that Promotes Pancreatic Cancer Growth. American Journal Of Pathology. 184(10). 2791–2802. 28 indexed citations

Liu, Chunsheng, Jiachu Li, Xiaoyu Xiang, et al.. (2014). PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors. American Journal of Physiology-Gastrointestinal and Liver Physiology. 307(7). G749–G759. 58 indexed citations

Tu, Kangsheng, Jiachu Li, Vikas Verma, et al.. (2014). Vasodilator‐stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11‐dependent plasma membrane targeting of transforming growth factor beta receptors. Hepatology. 61(1). 361–374. 63 indexed citations

10.

Li, Jiachu, Xin‐Rong Yang, Haixiang Sun, et al.. (2010). Up-regulation of Krüppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma. Gastroenterology. 139(6). 2146–2157.e12. 83 indexed citations

11.

Wu, Xiaoyun, et al.. (2009). Upregulation of GRP78 in Renal Cell Carcinoma and Its Significance. Urology. 75(3). 603–607. 31 indexed citations

12.

Ke, Ai‐Wu, Guo‐Ming Shi, Jian Zhou, et al.. (2008). Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma #. Hepatology. 49(2). 491–503. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact